A head-to-head study of 108 prostate cancer patients shows gallium-68 PSMA PET/CT detects bone metastases far more accurately ...

PSMA PET/CT-targeted biopsy detects more clinically significant prostate cancer than systematic biopsy alone in men with ...

A prospective study shows PSMA PET/CT-guided targeted biopsy detects clinically significant prostate cancer in 37 percent of ...

An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following inconclusive or reassuring results from an MRI scan, new research has found. Findings ...

Theranostics combine PSMA imaging with targeted radiation therapy to help locate and treat advanced prostate cancer using the ...

A case report led by UCLA Health researchers highlights the importance of a multidisciplinary, evidence-based approach to ...

A recent pilot study reported in the June issue of The Journal of Nuclear Medicine found that sodium fluoride (Na-F-18) positron emission tomography/computed tomography (NaF-PET/CT) accurately detects ...

Reviewing your results from a PSMA-PET scan can feel like you’re reading a foreign language, especially when you see unfamiliar terms like “SUVMax” and “radiotracer uptake.” But you don’t need a ...

Prostate-specific membrane antigen (PSMA)-PET is already a standard imaging tool in prostate cancer treatment. Now, a phase 3 clinical trial suggests the imaging modality may also help determine which ...

A new study by the Medical University of Vienna found that a specialized form of imaging could identify 91% of prostate ...

Prostate cancer cases are rising in India, but advances in diagnostics, targeted therapies and personalised treatment are ...